Rafferty Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $924K | Buy |
|
|||||
|
2025
Q1 | $397K | Buy |
|
|||||
|
2024
Q4 | $342K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $504K | Sell |
|
|||||
|
2021
Q4 | $1.67M | Buy |
|
|||||
|
2021
Q3 | $1.94M | Buy |
|
|||||
|
2021
Q2 | $2.25M | Sell |
|
|||||
|
2021
Q1 | $3.12M | Buy |
|
|||||
|
2020
Q4 | $823K | Sell |
|
|||||
|
2020
Q3 | $1.29M | Buy |
|
|||||
|
2020
Q2 | $582K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $361K | Sell |
|
|||||
|
2019
Q3 | $528K | Sell |
|
|||||
|
2019
Q2 | $1.45M | Buy |
|
|||||
|
2019
Q1 | $1.03M | Buy |
|